STIPE Therapeutics ApS: Financial statements 2024
CVR: 39691175
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
STIPE Therapeutics ApS (CVR 39691175) has filed annual accounts for 2024. In 2024, the company reported a gross profit of EUR -842,285 and a net result of EUR 1,448,748 compared with EUR -4,456,130 the year before. Equity in the 2024 report amounted to EUR 1,087,512. The solvency ratio was 96.8%. The company had 5 employees in the financial year.
- Gross Profit
- EUR -842,285
- Profit/Loss
- EUR 1,448,748
- Equity
- EUR 1,087,512
- Total Assets
- EUR 1,123,658
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -842 t. EUR | 1.4 mio. EUR | 1.1 mio. EUR | 5 |
| 2023 | - | -3.5 mio. EUR | -4.5 mio. EUR | -2.5 mio. EUR | 14 |
| 2022 | - | -6.6 mio. EUR | -8.3 mio. EUR | 2 mio. EUR | 16 |
| 2021 | - | -4.1 mio. EUR | -5.5 mio. EUR | 10.2 mio. EUR | 16 |
| 2020 | - | -2.9 mio. EUR | -3.9 mio. EUR | 3.8 mio. EUR | 14 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of August 21, 2024, Sten Verland has left the board of directors of STIPE Therapeutics ApS.
As of August 21, 2024, Morten Døssing has left the board of directors of STIPE Therapeutics ApS.
As of August 21, 2024, Martin Roelsgaard Jakobsen has left the board of directors of STIPE Therapeutics ApS.
As of August 21, 2024, Regina Hodits has left the board of directors of STIPE Therapeutics ApS.
As of August 21, 2024, Christian Schetter has left the board of directors of STIPE Therapeutics ApS.
As of August 21, 2024, Preben Jakobsen is registered as liquidator of STIPE Therapeutics ApS.
As of August 21, 2024, Claus Elsborg Olesen has stepped down as director of STIPE Therapeutics ApS.
On August 21, 2024, STIPE Therapeutics ApS entered liquidation.
STIPE Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -3,456,557, and the net result was DKK -4,456,130.
About STIPE Therapeutics ApS
STIPE Therapeutics ApS is a Danish company of the type Anpartsselskab based in København V, founded in 2018. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company's owners include CLAUS OLESEN HOLDING ApS, Novo Holdings A/S and Sunstone Life Science Ventures Fund IV K/S. The company has 1 employee (2024). In 2024, the company reported a gross profit of EUR -842,285 and a net result of EUR 1,448,748 compared with EUR -4,456,130 the year before. Equity in the 2024 report amounted to EUR 1,087,512.